Levator plate descent correlates with levator ani muscle deficiency.

AIMS: Measurements such as the minimal levator hiatus dimension, levator plate angle, iliococcygeal angle, and anorectal angle have been used for assessing the impact of levator damage on static and dynamic imaging features. The primary aim of this study was to investigate the association between levator ani muscle deficiency (LAD) and the position of the levator plate. METHODS: 3D endovaginal ultrasounds of 186 women were reviewed. The levator ani muscle groups, the puboanalis, puborectalis, and pubovisceralis, were scored for abnormalities, (0 no defect and 3 total absence of the muscle). The levator plate descent angle, minimal levator hiatus dimensions, and the anorectal angle were measured. Levator plate descent towards the perineum was assessed and correlated with levator ani muscle deficiency. RESULTS: The correlation between puborectalis scores and minimal levator hiatus area, anorectal angle and levator plate descent angle were 0.43 (P < 0.0001), 0.22 (P = 0.0045), and -0.40 (P < 0.0001), respectively. The correlation between pubovisceralis scores and minimal levator hiatus area, anorectal angle and levator plate descent angle were 0.36 (P < 0.0001), 0.38 (P < 0.0001), and -0.40 (P < 0.0001), respectively. The correlation between the total levator ani muscle scores and the minimal levator hiatus area, anorectal angle and the levator plate descent angle were 0.45 (P < 0.0001), 0.31 (P < 0.0001), and -0.45 (P < 0.0001) respectively. CONCLUSION: Worsening LAD score is associated with levator plate descensus and with decreasing levator plate descent angle. We can use levator plate descent angle along with the minimal levator hiatus and anorectal angle as objective measurements to assess levator ani muscle deficiency.

Risk factors for lower urinary tract injury at the time of hysterectomy for benign reasons.

OBJECTIVES: To identify risk factors associated with lower urinary tract injury at the time of performing hysterectomy for benign indications. METHODS: We conducted a multi-center case-control study of women undergoing hysterectomy for benign disease. Cases were identified via ICD-9 codes for lower urinary tract injury at the time of hysterectomy from 2007 to 2011: controls were two subsequent hysterectomies following the index case in the same institution that did not have lower urinary tract injury. Logistic regression was used to perform univariate and multivariate comparisons between groups. RESULTS: At 7 centers, 135 cases and 270 controls were identified. Cases comprised 118 bladder injuries and 25 ureteral injuries; 8 women had both bladder and ureteral injury. Bladder injury was associated with a history of prior cesarean section OR 2.9 (95% CI 1.7-5), surgery by a general obstetrician and gynecologist OR 2.4 (95% CI 1.2-5.2), and total abdominal hysterectomy OR1.9 (95%CI 1.06-3.4). Ureteral injury was more likely among women who underwent laparoscopic-assisted vaginal hysterectomy (LAVH) OR 10.4 (95%CI 2.3-46.6) and total abdominal hysterectomy (TAH) OR 4.7 (95% CI 1.4-15.6). CONCLUSION: Bladder injury at the time of benign hysterectomy is associated with a prior history of Cesarean section and TAH as well as surgery by generalist OB-GYN; ureteral injury is associated with LAVH and TAH.

Outcomes of abdominal and minimally invasive sacrocolpopexy: a retrospective cohort study.

OBJECTIVE: To compare perioperative and postoperative surgical outcomes between and among open and minimally invasive sacrocolpopexies (MISCs). METHODS: We performed a multicenter retrospective cohort study comparing abdominal sacrocolpopexy (ASC) and MISC from January 1999 to December 2010. RESULTS: A total of 1124 subjects underwent sacrocolpopexy, with 589 ASCs and 535 MISCs. Within the MISC group, 273 were laparoscopic (LSC) and 262 were robotic (RSC). Abdominal sacrocolpopexy was associated with greater overall complication rate compared with MISC (20.0% vs 12.7%; P = 0.001). After controlling for difference in length of follow-up, there was no significant difference in the rate of anatomical failure between the ASC and MISC groups. The MISC group had shorter hospitalization, less blood loss, but longer operative times compared with the ASC group. When comparing LSC to RSC, there was no difference in anatomic failures (7.7% vs 6.9%; P = 0.74). However, LSC was associated with more complications compared with RSC (18% vs 7%; P < 0.02). In addition, LSC had higher blood loss, less operative time, and shorter hospital stay compared with RSC. CONCLUSION: Although anatomic results are similar, ASC is associated with a higher rate of complications compared with MISC.

Age effects on pelvic floor symptoms in a cohort of nulliparous patients.

OBJECTIVES: This study aimed to investigate the effects of age on pelvic floor symptoms (PFSs) in nulliparous women. METHODS: Eighty community-dwelling nulliparous women, aged 21 to 70 years, were recruited. Pelvic floor support was assessed with pelvic organ prolapse quantification system. Participants completed the Pelvic Floor Distress Inventory 20 and Pelvic Floor Impact Questionnaire 7. Sexual function was assessed with the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire 12 and health status with the Short-Form Health Survey. The correlation between age and questionnaire scores was evaluated using Pearson coefficient. Logistic regression assessed predictors associated with PFS. RESULTS: Participants had a median age of 47 years, average body mass index of 28.3 kg/m, and most were white; 52.5% were healthy and 30% were postmenopausal. The most common stage of prolapse was stage I.Age was associated with slightly higher Pelvic Floor Distress Inventory-20 scores (r = 0.41, P = 0.002), corresponding to more bothersome PFS, and lower Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire-12 scores, corresponding to worsening sexual function with advancing age (r = -0.41, P = 0.0012). There was no association between age and overall Pelvic Floor Impact Questionnaire scores (P = 0.12). For symptomatic patients, logistic regression showed age to be associated with increased odds of having PFS [odds ratio (OR), 1.881; 95% confidence interval (CI), 1.216-2.91]. Menopausal status was not associated with increased odds of reporting symptoms (OR, 3.05; 95% CI, 0.80-11.62). When age and age by menopause were incorporated in the model, age remained a significant predictor of having PFS (OR, 1.78; 95% CI, 1.13-2.78). CONCLUSIONS: In this population of community-dwelling nulliparous women, age was associated with worsening sexual function and slightly increased odds of reporting symptoms of pelvic floor disorders.